Gladstone Institutional Advisory’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,564
Closed -$202K 868
2025
Q4
$202K Buy
+2,564
New +$203K 0.01% 761
2022
Q3
Sell
-9,684
Closed -$608K 661
2022
Q2
$608K Buy
+9,684
New +$641K 0.05% 365
2021
Q3
Sell
-14,214
Closed -$851K 579
2021
Q2
$851K Buy
14,214
+596
+4% +$37.8K 0.1% 212
2021
Q1
$828K Buy
+13,618
New +$752K 0.13% 167

Other funds holding MET

Gladstone Institutional Advisory's MET Position: Q1 2026 in Review

Gladstone Institutional Advisory sold out of MetLife (MET) in Q1 2026, closing a stake of 2,564 shares — an estimated $202K sold.

Gladstone Institutional Advisory first reported a position in MET in Q1 2021 and held it in 4 quarters. The position peaked at $851K in Q2 2021. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Gladstone Institutional Advisory reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 2,564 MetLife shares in Q1 2026, an estimated $202K.
  • Gladstone Institutional Advisory first reported a position in MetLife in Q1 2021 and held it in 4 quarters.
  • Gladstone Institutional Advisory's MetLife position peaked at $851K in Q2 2021.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.